| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 DNAH10 CENPE MYO9A SAE1 SRP54 YTHDC2 DNAH7 BPTF TRAP1 KIF3B CCT5 DNAH17 ATP2C2 ABCD3 SHOC1 CDC6 HSPA9 HSP90AA4P | 2.91e-08 | 614 | 148 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1C MYH1 FLNA MYH2 MAP2 CENPE MYO9A DCTN2 SPTA1 TPPP PSTPIP2 ARPC2 NEFM KIF3B DST BRCA2 CCT5 XIRP2 MYPN TLN2 TPPP3 SNX5 MYBPC1 MYBPC3 | 1.81e-06 | 1099 | 148 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.77e-06 | 118 | 148 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.71e-06 | 130 | 148 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 FLNA MYH2 MAP2 MYO9A SPTA1 PSTPIP2 ARPC2 DST XIRP2 MYPN TLN2 MYBPC1 MYBPC3 | 1.36e-05 | 479 | 148 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH10 SRP54 YTHDC2 DNAH7 TRAP1 KIF3B CCT5 ATP2C2 ABCD3 SHOC1 CDC6 HSPA9 HSP90AA4P | 2.55e-05 | 441 | 148 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | 5.05e-05 | 227 | 148 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.72e-04 | 70 | 148 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.15e-04 | 40 | 148 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.00e-04 | 18 | 148 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | polynucleotide 5'-hydroxyl-kinase activity | 3.24e-04 | 4 | 148 | 2 | GO:0051731 | |
| GeneOntologyMolecularFunction | ATP-dependent polynucleotide 5'-hydroxyl-kinase activity | 3.24e-04 | 4 | 148 | 2 | GO:0051734 | |
| GeneOntologyMolecularFunction | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity | 3.24e-04 | 4 | 148 | 2 | GO:0046404 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA SLK TNC DOCK9 RTN4 CDH19 PAICS PPL DST MYPN NUMB TLN2 SNX5 | 5.28e-04 | 599 | 148 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | cadherin binding | 9.79e-04 | 339 | 148 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.14e-03 | 28 | 148 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 4.03e-06 | 90 | 149 | 7 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 7.38e-06 | 138 | 149 | 8 | GO:2000278 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 8.69e-06 | 39 | 149 | 5 | GO:1904358 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 1.06e-05 | 69 | 149 | 6 | GO:1904356 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | FLNA SLK MAP2 CENPE DCTN2 TPPP CNTLN DNAH7 NEFM FSIP2 KIF3B DST BRCA2 DNAH17 NAT10 TPPP3 CFAP44 | 1.83e-05 | 720 | 149 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 2.00e-05 | 77 | 149 | 6 | GO:0007004 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 3.03e-05 | 218 | 149 | 9 | GO:0071897 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.07e-05 | 83 | 149 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 3.08e-05 | 168 | 149 | 8 | GO:0000723 | |
| GeneOntologyBiologicalProcess | chromosome organization | FLNA PNKP ATR CENPE DCTN2 HNRNPA2B1 PARP4 KIF3B AGO4 BRCA2 CCT5 CTCF NAT10 SHOC1 DKC1 CDC6 | 3.80e-05 | 686 | 149 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 7.29e-05 | 60 | 149 | 5 | GO:0032210 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 8.04e-05 | 32 | 149 | 4 | GO:0070198 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 8.96e-05 | 145 | 149 | 7 | GO:0001578 | |
| GeneOntologyBiologicalProcess | telomere organization | 1.02e-04 | 199 | 149 | 8 | GO:0032200 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomerase | 1.29e-04 | 36 | 149 | 4 | GO:0032212 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.40e-04 | 266 | 149 | 9 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 1.64e-04 | 112 | 149 | 6 | GO:0032204 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 1.74e-04 | 72 | 149 | 5 | GO:0032206 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 1.98e-04 | 74 | 149 | 5 | GO:0070918 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to telomere | 2.78e-04 | 18 | 149 | 3 | GO:0070200 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PNKP EXO5 ATP23 ATR APAF1 TDG E4F1 REV3L HNRNPA2B1 PARP4 BRCA2 CCT5 SLC15A4 N4BP2 NAT10 KCNK2 SHOC1 DKC1 CDC6 | 2.99e-04 | 1081 | 149 | 19 | GO:0006259 |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 3.08e-04 | 4 | 149 | 2 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 3.08e-04 | 4 | 149 | 2 | GO:0090625 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1C MYH1 FLNA MYH2 MYOM1 DNAH10 MAP2 CENPE MYO9A DCTN2 TPPP FAM161B PSTPIP2 DNAH7 PPL ARPC2 NEFM PARP4 KIF3B DST CCT5 XIRP2 DNAH17 MYPN TPPP3 MYBPC1 MYBPC3 | 5.72e-08 | 1179 | 148 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1C MYH1 FLNA MYH2 MYOM1 DNAH10 MAP2 CENPE MYO9A DCTN2 TPPP FAM161B PSTPIP2 DNAH7 PPL ARPC2 NEFM PARP4 KIF3B DST CCT5 XIRP2 DNAH17 MYPN TPPP3 MYBPC1 MYBPC3 | 6.57e-08 | 1187 | 148 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | myosin filament | 7.88e-07 | 25 | 148 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | A band | 1.77e-06 | 52 | 148 | 6 | GO:0031672 | |
| GeneOntologyCellularComponent | sarcomere | 1.16e-05 | 249 | 148 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | FLNA DNAH10 MAP2 CENPE MYO9A DCTN2 TPPP FAM161B PSTPIP2 DNAH7 PPL ARPC2 NEFM PARP4 KIF3B DST CCT5 DNAH17 TPPP3 | 2.02e-05 | 899 | 148 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | myofibril | 2.56e-05 | 273 | 148 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.28e-05 | 290 | 148 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | microtubule | DNAH10 MAP2 CENPE DCTN2 TPPP FAM161B DNAH7 PARP4 KIF3B DST CCT5 DNAH17 TPPP3 | 1.10e-04 | 533 | 148 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | dendritic shaft | 1.81e-04 | 74 | 148 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 FLNA MYH2 MAP2 MYO9A DCTN2 SPTA1 PSTPIP2 ARPC2 DST XIRP2 TLN2 TNS3 | 2.36e-04 | 576 | 148 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 2.96e-04 | 4 | 148 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | apoptosome | 2.96e-04 | 4 | 148 | 2 | GO:0043293 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 FLNA MYH2 TNC RTN4 YBX3 TEC CDH19 PPL ARPC2 DST XIRP2 SCN4B NUMB TLN2 HSPA9 TNS3 | 5.58e-04 | 976 | 148 | 17 | GO:0070161 |
| GeneOntologyCellularComponent | dynein complex | 5.80e-04 | 54 | 148 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.13e-04 | 25 | 148 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule bundle | 7.33e-04 | 6 | 148 | 2 | GO:0097427 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | FLNA SLK UACA TPPP YTHDC2 YBX3 ODC1 BPTF DST RHPN2 ATP2C2 PRKACB TPPP3 PREX1 SNX5 HSP90AA4P | 9.72e-04 | 934 | 148 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.02e-03 | 161 | 148 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.03e-03 | 287 | 148 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | M band | 1.35e-03 | 31 | 148 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | intercalated disc | 1.38e-03 | 68 | 148 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | apical dendrite | 1.48e-03 | 32 | 148 | 3 | GO:0097440 | |
| GeneOntologyCellularComponent | axon | CACNA1C FLNA MAP2 MYO9A DCTN2 SPTA1 BCAN ARPC2 NEFM KIF3B DST HMCN2 MYPN KCNK2 PREX1 | 1.67e-03 | 891 | 148 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | basement membrane | 1.77e-03 | 122 | 148 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.16e-03 | 10 | 148 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | RISC-loading complex | 2.16e-03 | 10 | 148 | 2 | GO:0070578 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 2.63e-03 | 11 | 148 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.10e-03 | 269 | 148 | 7 | GO:0036464 | |
| HumanPheno | Coiled sperm flagella | 1.48e-06 | 32 | 60 | 6 | HP:0032560 | |
| HumanPheno | Short sperm flagella | 1.79e-06 | 33 | 60 | 6 | HP:0032559 | |
| HumanPheno | Abnormal sperm tail morphology | 9.00e-06 | 43 | 60 | 6 | HP:0012868 | |
| HumanPheno | Clinodactyly of hands | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 1.77e-05 | 421 | 60 | 16 | HP:0001157 |
| HumanPheno | Radial deviation of finger | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 3.86e-05 | 448 | 60 | 16 | HP:0009466 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 4.79e-05 | 456 | 60 | 16 | HP:0009485 |
| HumanPheno | Clinodactyly of the 5th finger | AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 7.17e-05 | 420 | 60 | 15 | HP:0004209 |
| HumanPheno | Deviation of the 5th finger | AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 7.37e-05 | 421 | 60 | 15 | HP:0009179 |
| HumanPheno | Deviation of finger | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 MYBPC1 | 9.70e-05 | 537 | 60 | 17 | HP:0004097 |
| HumanPheno | Abnormal sperm morphology | 1.09e-04 | 66 | 60 | 6 | HP:0012864 | |
| HumanPheno | Abnormal germ cell morphology | 1.18e-04 | 67 | 60 | 6 | HP:0012862 | |
| HumanPheno | Abnormal male germ cell morphology | 1.18e-04 | 67 | 60 | 6 | HP:0012863 | |
| HumanPheno | Finger clinodactyly | AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 1.65e-04 | 452 | 60 | 15 | HP:0040019 |
| HumanPheno | Deviation of the hand or of fingers of the hand | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 MYBPC1 | 1.79e-04 | 564 | 60 | 17 | HP:0009484 |
| HumanPheno | Abnormal 5th finger morphology | FLNA AGO2 ATR CENPE GRB10 ODC1 REV3L PAICS BPTF BRCA2 CTCF TGDS PRKACB CDC6 SPEN MAN1B1 | 1.80e-04 | 509 | 60 | 16 | HP:0004207 |
| Domain | RNaseH-like_dom | 1.46e-05 | 69 | 143 | 6 | IPR012337 | |
| Domain | - | 2.90e-05 | 47 | 143 | 5 | 3.30.420.10 | |
| Domain | P25-alpha | 1.74e-04 | 3 | 143 | 2 | IPR008907 | |
| Domain | p25-alpha | 1.74e-04 | 3 | 143 | 2 | PF05517 | |
| Domain | Argonaute_N | 3.46e-04 | 4 | 143 | 2 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 3.46e-04 | 4 | 143 | 2 | IPR032473 | |
| Domain | ArgoL2 | 3.46e-04 | 4 | 143 | 2 | IPR032472 | |
| Domain | ArgoN | 3.46e-04 | 4 | 143 | 2 | PF16486 | |
| Domain | ArgoMid | 3.46e-04 | 4 | 143 | 2 | PF16487 | |
| Domain | ArgoL2 | 3.46e-04 | 4 | 143 | 2 | PF16488 | |
| Domain | DUF1785 | 5.73e-04 | 5 | 143 | 2 | SM01163 | |
| Domain | DUF3398 | 8.56e-04 | 6 | 143 | 2 | PF11878 | |
| Domain | ArgoL1 | 8.56e-04 | 6 | 143 | 2 | PF08699 | |
| Domain | ArgoL1 | 8.56e-04 | 6 | 143 | 2 | IPR014811 | |
| Domain | DOCK_C/D_N | 8.56e-04 | 6 | 143 | 2 | IPR021816 | |
| Domain | Plectin | 1.19e-03 | 7 | 143 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.19e-03 | 7 | 143 | 2 | IPR001101 | |
| Domain | PLEC | 1.19e-03 | 7 | 143 | 2 | SM00250 | |
| Domain | Spectrin_repeat | 1.39e-03 | 29 | 143 | 3 | IPR002017 | |
| Domain | PIWI | 1.58e-03 | 8 | 143 | 2 | PS50822 | |
| Domain | Piwi | 1.58e-03 | 8 | 143 | 2 | SM00950 | |
| Domain | Piwi | 1.58e-03 | 8 | 143 | 2 | PF02171 | |
| Domain | Piwi | 1.58e-03 | 8 | 143 | 2 | IPR003165 | |
| Domain | A2M_N_2 | 1.58e-03 | 8 | 143 | 2 | SM01359 | |
| Domain | - | 1.58e-03 | 8 | 143 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.58e-03 | 8 | 143 | 2 | SM01361 | |
| Domain | A2M | 1.58e-03 | 8 | 143 | 2 | SM01360 | |
| Domain | SPEC | 1.85e-03 | 32 | 143 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.85e-03 | 32 | 143 | 3 | IPR018159 | |
| Domain | PAZ | 2.02e-03 | 9 | 143 | 2 | PS50821 | |
| Domain | PAZ | 2.02e-03 | 9 | 143 | 2 | SM00949 | |
| Domain | PAZ | 2.02e-03 | 9 | 143 | 2 | PF02170 | |
| Domain | R3H | 2.02e-03 | 9 | 143 | 2 | SM00393 | |
| Domain | PAZ_dom | 2.02e-03 | 9 | 143 | 2 | IPR003100 | |
| Domain | A2M | 2.52e-03 | 10 | 143 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.52e-03 | 10 | 143 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.52e-03 | 10 | 143 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.52e-03 | 10 | 143 | 2 | PF07677 | |
| Domain | A2M_comp | 2.52e-03 | 10 | 143 | 2 | PF07678 | |
| Domain | A2M_N | 2.52e-03 | 10 | 143 | 2 | PF01835 | |
| Domain | A2M_N | 2.52e-03 | 10 | 143 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.52e-03 | 10 | 143 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.52e-03 | 10 | 143 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.52e-03 | 10 | 143 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.52e-03 | 10 | 143 | 2 | IPR001599 | |
| Domain | FN3 | 3.04e-03 | 185 | 143 | 6 | SM00060 | |
| Domain | Myosin_head_motor_dom | 3.05e-03 | 38 | 143 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.05e-03 | 38 | 143 | 3 | PS51456 | |
| Domain | Myosin_head | 3.05e-03 | 38 | 143 | 3 | PF00063 | |
| Domain | MYSc | 3.05e-03 | 38 | 143 | 3 | SM00242 | |
| Domain | R3H | 3.06e-03 | 11 | 143 | 2 | PS51061 | |
| Domain | DHR-1_domain | 3.06e-03 | 11 | 143 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.06e-03 | 11 | 143 | 2 | PS51651 | |
| Domain | DHR_1 | 3.06e-03 | 11 | 143 | 2 | PS51650 | |
| Domain | DHR-2 | 3.06e-03 | 11 | 143 | 2 | PF06920 | |
| Domain | DOCK | 3.06e-03 | 11 | 143 | 2 | IPR026791 | |
| Domain | R3H | 3.06e-03 | 11 | 143 | 2 | PF01424 | |
| Domain | - | 3.06e-03 | 11 | 143 | 2 | 3.30.1370.50 | |
| Domain | DOCK_C | 3.06e-03 | 11 | 143 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.06e-03 | 11 | 143 | 2 | PF14429 | |
| Domain | DHR-2 | 3.06e-03 | 11 | 143 | 2 | IPR027357 | |
| Domain | R3H_dom | 3.06e-03 | 11 | 143 | 2 | IPR001374 | |
| Domain | VWFA | 3.63e-03 | 82 | 143 | 4 | PS50234 | |
| Domain | - | 3.65e-03 | 12 | 143 | 2 | 1.50.10.20 | |
| Domain | VWA | 3.96e-03 | 84 | 143 | 4 | SM00327 | |
| Domain | FN3 | 4.34e-03 | 199 | 143 | 6 | PS50853 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.99e-03 | 14 | 143 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.99e-03 | 14 | 143 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.99e-03 | 14 | 143 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.99e-03 | 14 | 143 | 2 | PF08393 | |
| Domain | MT | 4.99e-03 | 14 | 143 | 2 | PF12777 | |
| Domain | AAA_8 | 4.99e-03 | 14 | 143 | 2 | PF12780 | |
| Domain | AAA | 5.04e-03 | 144 | 143 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 5.04e-03 | 144 | 143 | 5 | IPR003593 | |
| Domain | FN3_dom | 5.49e-03 | 209 | 143 | 6 | IPR003961 | |
| Domain | P-loop_NTPase | MYH1 MYH2 PNKP DNAH10 CENPE MYO9A APAF1 SRP54 YTHDC2 DNAH7 KIF3B N4BP2 ABCD3 CDC6 | 5.58e-03 | 848 | 143 | 14 | IPR027417 |
| Domain | DHC_fam | 5.73e-03 | 15 | 143 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.73e-03 | 15 | 143 | 2 | PF03028 | |
| Domain | Myosin_N | 5.73e-03 | 15 | 143 | 2 | PF02736 | |
| Domain | Dynein_heavy_dom | 5.73e-03 | 15 | 143 | 2 | IPR004273 | |
| Domain | Myosin_N | 5.73e-03 | 15 | 143 | 2 | IPR004009 | |
| Domain | EF-hand-dom_pair | 6.68e-03 | 287 | 143 | 7 | IPR011992 | |
| Domain | VWF_A | 7.07e-03 | 99 | 143 | 4 | IPR002035 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA SLK AGO2 UACA RTN4 SRP54 YTHDC2 YBX3 PSTPIP2 ARPC2 PARP4 TRAP1 CCT5 RBM19 NOM1 NAT10 DKC1 SPEN MAP2K3 TNS3 | 5.90e-11 | 724 | 151 | 20 | 36232890 |
| Pubmed | CACNA1C MYH1 FLNA MYH2 ACADVL SPTA1 YBX3 AHCYL2 SRBD1 HNRNPA2B1 PPL ARPC2 NEFM BPTF TRAP1 DST N4BP2 PRKACB FUNDC2 DKC1 PDIA2 HSD17B4 SPEN PREX1 HSPA9 MYBPC1 | 7.11e-10 | 1442 | 151 | 26 | 35575683 | |
| Pubmed | FLNA DCTN2 ETFB YTHDC2 YBX3 SRBD1 KRR1 HNRNPA2B1 PAICS NKRF NEFM CCT5 N4BP2 NAT10 DKC1 HSPA9 | 2.72e-09 | 551 | 151 | 16 | 34728620 | |
| Pubmed | SRBD1 KRR1 SARNP NCBP3 BPTF TRAP1 DST CTCF ABCD3 NUMB TLN2 HSD17B4 MAP2K3 TNS3 | 2.16e-08 | 472 | 151 | 14 | 38943005 | |
| Pubmed | FLNA UACA DCTN2 DOCK9 ETFB SRP54 YTHDC2 YBX3 AHCYL2 KRR1 DNAH7 HNRNPA2B1 PAICS NKRF TRAP1 CCT5 CTCF NAT10 LSM2 HSPA9 HSP90AA4P | 3.11e-08 | 1153 | 151 | 21 | 29845934 | |
| Pubmed | FLNA PNKP DOCK8 FAM161B TDG E4F1 PIAS2 PPL ZNF518A KIF3B DST RBM19 NOM1 CFDP1 PLCL2 | 5.15e-08 | 591 | 151 | 15 | 15231748 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA SLK ATR DNAH10 RTN4 ETFB YTHDC2 YBX3 KRR1 HNRNPA2B1 PAICS ARPC2 TRAP1 CCT5 RBM19 NAT10 ABCD3 DKC1 TLN2 HSD17B4 SPEN HSPA9 MYBPC1 | 5.84e-08 | 1425 | 151 | 23 | 30948266 |
| Pubmed | FLNA SLK AGO2 MAP2 MYO9A DOCK8 TNC DCTN2 SPTA1 RTN4 ETFB TPPP YTHDC2 BCAN HNRNPA2B1 ARPC2 NEFM DST TTC7B CCT5 ABCD3 TLN2 HSPA9 | 6.30e-08 | 1431 | 151 | 23 | 37142655 | |
| Pubmed | FLNA SLK AGO2 DCTN2 PAICS NKRF NEFM BPTF CCT5 NAT10 NUMB QSER1 SPEN ZMYM4 | 1.38e-07 | 549 | 151 | 14 | 38280479 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | AGO2 MYO9A DCTN2 RTN4 YTHDC2 CNTLN KRR1 NKRF PPL PARP4 TRAP1 CCT5 NOM1 ABCD3 NUMB C5 | 1.39e-07 | 732 | 151 | 16 | 34732716 |
| Pubmed | 1.42e-07 | 187 | 151 | 9 | 26460568 | ||
| Pubmed | SLK AGO2 HECW1 UACA CENPE TPPP ARMCX4 ARPC2 NEFM KIF3B DST CTCF N4BP2 NAT10 PRKACB TLN2 QSER1 HSPA9 | 2.24e-07 | 963 | 151 | 18 | 28671696 | |
| Pubmed | AGO2 UACA ACADVL YTHDC2 KRR1 NKRF NCBP3 CTCF RBM19 NAT10 DKC1 | 2.49e-07 | 332 | 151 | 11 | 25693804 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | ATR GRB10 YBX3 NKRF NCBP3 DST CTCF ABCD3 QSER1 LSM2 SPEN ZMYM4 | 2.64e-07 | 410 | 151 | 12 | 26949251 |
| Pubmed | COL12A1 MYOM1 UACA SGCG DOCK9 PARP4 DST XIRP2 MYPN HSPA9 ZMYM4 SNX5 MYBPC1 | 2.96e-07 | 497 | 151 | 13 | 23414517 | |
| Pubmed | MON2 FLNA MYH2 PNKP UACA DCTN2 RTN4 CD109 YTHDC2 YBX3 KRR1 PAICS NKRF ARPC2 NCBP3 TRAP1 DST CCT5 NOM1 NAT10 ABCD3 DKC1 | 2.99e-07 | 1440 | 151 | 22 | 30833792 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | FLNA AGO2 YTHDC2 YBX3 SRBD1 KRR1 HNRNPA2B1 NKRF CCT5 RBM19 NOM1 NAT10 DKC1 QSER1 HSPA9 | 3.00e-07 | 678 | 151 | 15 | 30209976 |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | DCTN2 RTN4 SAE1 SRP54 HNRNPA2B1 PAICS TRAP1 CCT5 PREX1 HSPA9 | 3.12e-07 | 269 | 151 | 10 | 30442662 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA AGO2 MYO9A SAE1 SRP54 YBX3 SRBD1 KRR1 HNRNPA2B1 PAICS NKRF DST CCT5 RBM19 NAT10 ABCD3 DKC1 PRR14L MAP2K3 HSPA9 TNS3 | 4.43e-07 | 1353 | 151 | 21 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA ACADVL ETFB YTHDC2 HNRNPA2B1 NKRF ARPC2 NCBP3 BPTF TRAP1 DST CCT5 NAT10 ABCD3 DKC1 HSD17B4 SPEN HSPA9 | 5.45e-07 | 1024 | 151 | 18 | 24711643 |
| Pubmed | FLNA AGO2 UACA ETFB SAE1 SRP54 YBX3 KRR1 HNRNPA2B1 NKRF NCBP3 TRAP1 CCT5 CTCF RBM19 NOM1 NAT10 DKC1 NUMB C5 HSPA9 | 5.48e-07 | 1371 | 151 | 21 | 36244648 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACADVL CENPE RTN4 ETFB SRP54 YTHDC2 YBX3 AHCYL2 ARMCX4 HNRNPA2B1 NKRF TRAP1 GK DST CCT5 NOM1 NAT10 ABCD3 FUNDC2 DKC1 HSD17B4 HSPA9 | 5.67e-07 | 1496 | 151 | 22 | 32877691 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA UACA CD109 YTHDC2 YBX3 SRBD1 KRR1 HNRNPA2B1 PAICS NKRF PPL ARPC2 DST CCT5 RBM19 NOM1 NAT10 ABCD3 SPEN HSPA9 | 5.82e-07 | 1257 | 151 | 20 | 36526897 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA SLK RTN4 HLCS SRP54 YTHDC2 NKRF TRAP1 DST CTCF NAT10 CFDP1 ABCD3 DKC1 NUMB PRR14L HSPA9 | 7.16e-07 | 934 | 151 | 17 | 33916271 |
| Pubmed | 7.94e-07 | 116 | 151 | 7 | 21282530 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 7.97e-07 | 5 | 151 | 3 | 30737693 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PNKP ATR SPTA1 E4F1 SRBD1 HNRNPA2B1 NKRF BPTF YAF2 DST CTCF NOM1 NAT10 DKC1 QSER1 LSM2 CDC6 SPEN HSPA9 ZMYM4 | 9.12e-07 | 1294 | 151 | 20 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA YBX3 KRR1 SARNP HNRNPA2B1 NKRF NCBP3 BPTF BRCA2 CTCF RBM19 WBP4 NAT10 DKC1 QSER1 SPEN ZMYM4 | 9.56e-07 | 954 | 151 | 17 | 36373674 |
| Pubmed | SLK ATR RTN4 YTHDC2 NKRF FREM2 PARP4 DST RHPN2 NOM1 ABCD3 QSER1 HSD17B4 MAN1B1 | 1.04e-06 | 650 | 151 | 14 | 38777146 | |
| Pubmed | AGO2 YTHDC2 YBX3 SRBD1 HNRNPA2B1 PAICS NKRF TRAP1 DKC1 LSM2 HSD17B4 HSPA9 | 1.09e-06 | 469 | 151 | 12 | 37314180 | |
| Pubmed | 1.61e-06 | 250 | 151 | 9 | 33536335 | ||
| Pubmed | MAP2 DCTN2 RTN4 TPPP AHCYL2 HNRNPA2B1 ARPC2 NEFM CCT5 PRKACB HSPA9 | 1.66e-06 | 403 | 151 | 11 | 30562941 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR DOCK8 DCTN2 SRP54 YTHDC2 PSTPIP2 HNRNPA2B1 PARP4 TRAP1 CCT5 NAT10 TLN2 MAP2K3 | 1.73e-06 | 582 | 151 | 13 | 20467437 |
| Pubmed | 2.03e-06 | 191 | 151 | 8 | 33762435 | ||
| Pubmed | FLNA PNKP AGO2 UACA DCTN2 RTN4 SAE1 HMGCS1 HNRNPA2B1 NKRF ARPC2 YAF2 CCT5 CTCF NAT10 ABCD3 MAP2K3 HSPA9 TNS3 | 2.16e-06 | 1247 | 151 | 19 | 27684187 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 SLK AGO2 ATR UACA TEC PAICS YAF2 DST AGO4 PRKACB NUMB MAP2K3 HSPA9 TNS3 | 2.42e-06 | 910 | 151 | 16 | 36736316 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FLNA AGO2 YTHDC2 YBX3 KRR1 SARNP HNRNPA2B1 NKRF NCBP3 RBM19 NOM1 NAT10 LSM2 SPEN HSPA9 | 2.60e-06 | 807 | 151 | 15 | 22681889 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | PNKP DCTN2 RTN4 SRP54 YBX3 HMGCS1 KRR1 HNRNPA2B1 CCT5 NOM1 WBP4 CDC6 HSPA9 SNX5 | 2.63e-06 | 704 | 151 | 14 | 32994395 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FLNA DCTN2 YBX3 KRR1 SARNP HNRNPA2B1 PAICS NKRF NCBP3 CCT5 WBP4 LSM2 HSD17B4 HSPA9 | 3.09e-06 | 714 | 151 | 14 | 28302793 |
| Pubmed | 3.10e-06 | 347 | 151 | 10 | 17114649 | ||
| Pubmed | FLNA PNKP AGO2 CENPE DOCK8 DOCK9 KRR1 HNRNPA2B1 PAICS PARP4 TRAP1 KIF3B AGO4 RBM19 NAT10 ABCD3 MAP2K3 MAN1B1 | 3.49e-06 | 1168 | 151 | 18 | 19946888 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MAP2 DOCK8 SPTA1 ETFB BCAN HNRNPA2B1 NEFM TRAP1 DST BRCA2 CCT5 PRKACB HSPA9 | 3.50e-06 | 621 | 151 | 13 | 22794259 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA UACA CD109 YBX3 HNRNPA2B1 NKRF ARPC2 DST CCT5 NOM1 NAT10 DKC1 NUMB MAP2K3 HSPA9 HSP90AA4P | 4.12e-06 | 949 | 151 | 16 | 36574265 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 4.40e-06 | 361 | 151 | 10 | 26167880 | |
| Pubmed | MYH1 FLNA DCTN2 RTN4 SAE1 SARNP HNRNPA2B1 ARPC2 DST CCT5 DKC1 HSPA9 | 4.45e-06 | 538 | 151 | 12 | 28524877 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 4.62e-06 | 363 | 151 | 10 | 14691545 | |
| Pubmed | MYH2 TRAPPC11 TNC REV3L PIAS2 DNAH7 PARP4 LRR1 WBP4 C5 SPEN PREX1 IGSF3 | 4.68e-06 | 638 | 151 | 13 | 31182584 | |
| Pubmed | FLNA YTHDC2 KRR1 PAICS NKRF NEFM BPTF DST CCT5 CTCF NAT10 SPEN HSPA9 | 6.01e-06 | 653 | 151 | 13 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPE YTHDC2 YBX3 SRBD1 KRR1 SARNP HNRNPA2B1 NKRF NCBP3 BPTF NOM1 NAT10 DKC1 CDC6 | 6.21e-06 | 759 | 151 | 14 | 35915203 |
| Pubmed | FLNA PNKP UACA CD109 YBX3 SARNP HNRNPA2B1 ARPC2 NCBP3 DST NAT10 DKC1 LSM2 | 6.74e-06 | 660 | 151 | 13 | 32780723 | |
| Pubmed | 6.80e-06 | 225 | 151 | 8 | 12168954 | ||
| Pubmed | PNKP UACA SRP54 YTHDC2 E4F1 SRBD1 KRR1 NKRF GREB1L DST CCT5 CTCF RBM19 NOM1 ABCD3 NUMB SPEN PREX1 ZMYM4 MAN1B1 | 8.13e-06 | 1497 | 151 | 20 | 31527615 | |
| Pubmed | Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle. | 9.41e-06 | 10 | 151 | 3 | 29679560 | |
| Pubmed | MON2 FLNA HECW1 ACADVL MAP2 DOCK9 RTN4 ETFB SNRK HMGCS1 AHCYL2 TRAP1 CCT5 ABCD3 TLN2 HSPA9 IGSF3 | 1.01e-05 | 1139 | 151 | 17 | 36417873 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.08e-05 | 316 | 151 | 9 | 31665637 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNA PNKP MAP2 RTN4 APAF1 HNRNPA2B1 NEFM DST NAT10 ABCD3 TLN2 | 1.23e-05 | 498 | 151 | 11 | 36634849 |
| Pubmed | ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma. | 1.27e-05 | 33 | 151 | 4 | 36414381 | |
| Pubmed | 1.29e-05 | 11 | 151 | 3 | 18310078 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.29e-05 | 11 | 151 | 3 | 38303699 | |
| Pubmed | Mouse numb is an essential gene involved in cortical neurogenesis. | 1.29e-05 | 11 | 151 | 3 | 10841580 | |
| Pubmed | 1.34e-05 | 247 | 151 | 8 | 30713523 | ||
| Pubmed | 1.55e-05 | 331 | 151 | 9 | 29199018 | ||
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 1.72e-05 | 12 | 151 | 3 | 8618961 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA ACADVL ETFB HLCS SAE1 HMGCS1 KRR1 HNRNPA2B1 PAICS NKRF TRAP1 CCT5 NAT10 ABCD3 DKC1 HSD17B4 MAP2K3 HSPA9 | 1.79e-05 | 1318 | 151 | 18 | 30463901 |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 12628722 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.87e-05 | 2 | 151 | 2 | 9585413 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16575183 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 18716213 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.87e-05 | 2 | 151 | 2 | 22337492 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28075014 | ||
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.87e-05 | 2 | 151 | 2 | 11551968 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22179839 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19154794 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 1.87e-05 | 2 | 151 | 2 | 7545970 | |
| Pubmed | Analysis of the local organization and dynamics of cellular actin networks. | 1.87e-05 | 2 | 151 | 2 | 24081490 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26321640 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 FLNA SLK MAP2 DCTN2 SAE1 YBX3 SARNP HNRNPA2B1 PAICS ARPC2 TRAP1 CCT5 PRKACB LSM2 HSPA9 TNS3 SNX5 HSP90AA4P | 1.91e-05 | 1455 | 151 | 19 | 22863883 |
| Pubmed | 2.00e-05 | 430 | 151 | 10 | 32581705 | ||
| Pubmed | MYH1 FLNA MYH2 ACADVL MYO9A HNRNPA2B1 PAICS NEFM DST CCT5 NOM1 MYPN NAT10 HSPA9 | 2.03e-05 | 844 | 151 | 14 | 25963833 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNA SLK DCTN2 ETFB SAE1 YBX3 HNRNPA2B1 ARPC2 NEFM CCT5 TLN2 MAP2K3 HSPA9 HSP90AA4P | 2.11e-05 | 847 | 151 | 14 | 35235311 |
| Pubmed | DCTN2 SRP54 YBX3 KRR1 SARNP HNRNPA2B1 PAICS TRAP1 HMCN2 CCT5 NOM1 PRKACB ABCD3 DKC1 LSM2 HSD17B4 HSPA9 HSP90AA4P | 2.12e-05 | 1335 | 151 | 18 | 29229926 | |
| Pubmed | 2.22e-05 | 13 | 151 | 3 | 37228035 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AGO2 CENPE DCTN2 HLCS CNTLN DNAH7 ARPC2 BRCA2 CCT5 N4BP2 PRKACB DKC1 HSD17B4 HSPA9 | 2.28e-05 | 853 | 151 | 14 | 28718761 |
| Pubmed | FLNA DCTN2 SRP54 YTHDC2 YBX3 TEC KRR1 HNRNPA2B1 NKRF PARP4 YAF2 CCT5 NAT10 LSM2 HSPA9 | 2.32e-05 | 971 | 151 | 15 | 33306668 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 FLNA RTN4 CD109 SAE1 YTHDC2 PSTPIP2 HNRNPA2B1 PAICS PPL CCT5 ABCD3 MAN1B1 TNS3 HSP90AA4P | 2.40e-05 | 974 | 151 | 15 | 28675297 |
| Pubmed | 2.48e-05 | 441 | 151 | 10 | 31239290 | ||
| Pubmed | FLNA DOCK8 SAE1 SRP54 HMGCS1 SARNP HNRNPA2B1 PAICS BPTF CCT5 QSER1 LSM2 HSD17B4 SPEN HSPA9 ZMYM4 | 2.63e-05 | 1103 | 151 | 16 | 34189442 | |
| Pubmed | 2.82e-05 | 274 | 151 | 8 | 34244482 | ||
| Pubmed | 2.82e-05 | 14 | 151 | 3 | 9373155 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA SRBD1 KRR1 HNRNPA2B1 PAICS NKRF BPTF TRAP1 CCT5 CTCF RBM19 NAT10 ABCD3 DKC1 HSPA9 | 2.87e-05 | 989 | 151 | 15 | 36424410 |
| Pubmed | FLNA SLK DCTN2 RTN4 KRR1 NKRF NCBP3 WBP4 NAT10 CFDP1 DKC1 HSPA9 | 3.04e-05 | 653 | 151 | 12 | 33742100 | |
| Pubmed | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. | 3.05e-05 | 41 | 151 | 4 | 18157088 | |
| Pubmed | AGO2 MAP2 DCTN2 RTN4 TPPP SAE1 HNRNPA2B1 PAICS ARPC2 CCT5 HSPA9 | 3.17e-05 | 552 | 151 | 11 | 36293380 | |
| Pubmed | 3.19e-05 | 83 | 151 | 5 | 35124280 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 AGO2 DCTN2 ETFB SAE1 YBX3 HNRNPA2B1 PAICS NKRF TRAP1 CCT5 NOM1 ABCD3 DKC1 CDC6 HSD17B4 HSPA9 | 3.51e-05 | 1257 | 151 | 17 | 37317656 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA EXO5 ATR UACA YTHDC2 YBX3 HNRNPA2B1 PPL BPTF DKC1 TLN2 SPEN ZMYM4 | 3.57e-05 | 774 | 151 | 13 | 15302935 |
| Pubmed | 3.69e-05 | 208 | 151 | 7 | 11790298 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.69e-05 | 208 | 151 | 7 | 33230847 | |
| Pubmed | 3.72e-05 | 285 | 151 | 8 | 21423176 | ||
| Pubmed | 3.80e-05 | 209 | 151 | 7 | 36779422 | ||
| Interaction | MYBPC2 interactions | 9.11e-07 | 45 | 148 | 6 | int:MYBPC2 | |
| Interaction | PLEC interactions | FLNA SLK ATR MAP2 MYO9A SPTA1 KRR1 PAICS NCBP3 NEFM DST BRCA2 N4BP2 QSER1 | 3.59e-06 | 430 | 148 | 14 | int:PLEC |
| Interaction | SOX2 interactions | FLNA AGO2 MYO9A DCTN2 RTN4 SRP54 YTHDC2 CNTLN KRR1 HNRNPA2B1 NKRF PPL ARPC2 BPTF PARP4 TRAP1 CCT5 CTCF NOM1 NAT10 ABCD3 NUMB C5 QSER1 LSM2 SPEN HSPA9 | 4.50e-06 | 1422 | 148 | 27 | int:SOX2 |
| Interaction | IFI16 interactions | FLNA AGO2 UACA ACADVL DCTN2 YTHDC2 YBX3 E4F1 SRBD1 KRR1 NKRF NCBP3 CCT5 CTCF RBM19 NAT10 DKC1 HSPA9 | 5.20e-06 | 714 | 148 | 18 | int:IFI16 |
| Interaction | H2BC9 interactions | MYH2 DNAH10 EXD1 HNRNPA2B1 ADGRG4 FSIP2 BPTF PARP4 DST XIRP2 WBP4 CFDP1 PRKACB CFAP44 | 5.46e-06 | 446 | 148 | 14 | int:H2BC9 |
| Interaction | CBX6 interactions | YTHDC2 YBX3 SRBD1 KRR1 NKRF USP26 BPTF YAF2 CTCF NAT10 ZMYM4 | 8.04e-06 | 283 | 148 | 11 | int:CBX6 |
| Interaction | H2AC17 interactions | 8.58e-06 | 232 | 148 | 10 | int:H2AC17 | |
| Interaction | PRKACB interactions | 1.31e-05 | 193 | 148 | 9 | int:PRKACB | |
| Interaction | FGD5 interactions | 2.29e-05 | 207 | 148 | 9 | int:FGD5 | |
| Interaction | NR3C1 interactions | MYH2 TRAPPC11 ACADVL TNC RTN4 FAM161B TDG REV3L PIAS2 DNAH7 PARP4 LRR1 TRAP1 WBP4 C5 HSD17B4 SPEN PREX1 HSPA9 IGSF3 | 3.06e-05 | 974 | 148 | 20 | int:NR3C1 |
| Interaction | TP73 interactions | 3.61e-05 | 169 | 148 | 8 | int:TP73 | |
| Interaction | YAP1 interactions | FLNA SLK HECW1 UACA MAP2 DCTN2 RTN4 HNRNPA2B1 PAICS NKRF NEFM BPTF TRAP1 CCT5 NAT10 ABCD3 NUMB SPEN HSPA9 ZMYM4 HSP90AA4P | 5.15e-05 | 1095 | 148 | 21 | int:YAP1 |
| Interaction | NUP43 interactions | FLNA DCTN2 NKRF ZNF518A NCBP3 FSIP2 BPTF DST BRCA2 CCT5 CTCF RBM19 DKC1 SPEN ZMYM4 | 5.84e-05 | 625 | 148 | 15 | int:NUP43 |
| Interaction | MYH6 interactions | 6.78e-05 | 94 | 148 | 6 | int:MYH6 | |
| Interaction | SHANK3 interactions | FLNA SLK HECW1 MAP2 DCTN2 RTN4 TPPP ARPC2 NEFM KIF3B CCT5 XIRP2 TLN2 | 7.74e-05 | 496 | 148 | 13 | int:SHANK3 |
| Interaction | SRPK2 interactions | STON1 YTHDC2 YBX3 KRR1 NKRF NCBP3 HMCN2 CTCF RBM19 NOM1 NAT10 DKC1 SPEN MAP2K3 ZMYM4 TNS3 | 7.74e-05 | 717 | 148 | 16 | int:SRPK2 |
| Interaction | KCTD13 interactions | FLNA SLK AGO2 MAP2 MYO9A DOCK8 TNC DCTN2 SPTA1 RTN4 ETFB TPPP YTHDC2 BCAN AHCYL2 HNRNPA2B1 ARPC2 NEFM DST TTC7B CCT5 ABCD3 TLN2 HSPA9 | 7.90e-05 | 1394 | 148 | 24 | int:KCTD13 |
| Interaction | MKI67 interactions | ATR CENPE GRB10 YBX3 HNRNPA2B1 NKRF NCBP3 DST BRCA2 CTCF ABCD3 QSER1 LSM2 SPEN ZMYM4 | 8.74e-05 | 648 | 148 | 15 | int:MKI67 |
| Interaction | SRSF6 interactions | YTHDC2 YBX3 SRBD1 KRR1 NKRF NCBP3 BPTF CTCF RBM19 NOM1 NAT10 DKC1 SPEN | 8.90e-05 | 503 | 148 | 13 | int:SRSF6 |
| Interaction | DYSF interactions | 9.22e-05 | 62 | 148 | 5 | int:DYSF | |
| Interaction | NAA11 interactions | 9.22e-05 | 62 | 148 | 5 | int:NAA11 | |
| Interaction | PPIA interactions | ETFB SRBD1 KRR1 SARNP PIAS2 HNRNPA2B1 NCBP3 BPTF TRAP1 DST CTCF WBP4 ABCD3 NUMB TLN2 HSD17B4 MAP2K3 TNS3 | 9.27e-05 | 888 | 148 | 18 | int:PPIA |
| Interaction | SCARB2 interactions | 9.88e-05 | 195 | 148 | 8 | int:SCARB2 | |
| Interaction | MCPH1 interactions | 1.01e-04 | 101 | 148 | 6 | int:MCPH1 | |
| Interaction | GAN interactions | 1.08e-04 | 253 | 148 | 9 | int:GAN | |
| Interaction | TSPAN33 interactions | 1.16e-04 | 65 | 148 | 5 | int:TSPAN33 | |
| Interaction | FGFBP1 interactions | 1.22e-04 | 257 | 148 | 9 | int:FGFBP1 | |
| Interaction | RPSA2 interactions | 1.33e-04 | 152 | 148 | 7 | int:RPSA2 | |
| Interaction | SMC5 interactions | MYH1 FLNA YBX3 REV3L KRR1 SARNP HNRNPA2B1 NKRF NCBP3 BPTF BRCA2 CTCF RBM19 WBP4 NAT10 DKC1 QSER1 SPEN ZMYM4 | 1.36e-04 | 1000 | 148 | 19 | int:SMC5 |
| Interaction | C1QTNF9 interactions | 1.53e-04 | 37 | 148 | 4 | int:C1QTNF9 | |
| Interaction | XRCC6 interactions | PNKP AGO2 ATP23 SPTA1 YTHDC2 SARNP PIAS2 BPTF YAF2 BRCA2 CCT5 WBP4 NAT10 CFDP1 PRKACB HSD17B4 SPEN HSPA9 | 1.61e-04 | 928 | 148 | 18 | int:XRCC6 |
| Interaction | MYCN interactions | FLNA AGO2 MAP2 YTHDC2 YBX3 ODC1 SRBD1 KRR1 SARNP HNRNPA2B1 NKRF PPL NCBP3 NEFM YAF2 CTCF RBM19 NOM1 WBP4 NAT10 DKC1 NUMB HSPA9 | 1.70e-04 | 1373 | 148 | 23 | int:MYCN |
| Interaction | TERT interactions | 1.70e-04 | 111 | 148 | 6 | int:TERT | |
| Interaction | PRKRA interactions | 1.85e-04 | 400 | 148 | 11 | int:PRKRA | |
| Interaction | LARP7 interactions | FLNA DCTN2 SAE1 SRP54 YTHDC2 YBX3 E4F1 SRBD1 KRR1 HNRNPA2B1 NKRF TRAP1 CCT5 CTCF RBM19 NAT10 DKC1 LSM2 HSPA9 HSP90AA4P | 1.89e-04 | 1113 | 148 | 20 | int:LARP7 |
| Interaction | NEIL1 interactions | 2.08e-04 | 276 | 148 | 9 | int:NEIL1 | |
| Interaction | MARK1 interactions | 2.14e-04 | 74 | 148 | 5 | int:MARK1 | |
| Interaction | THAP3 interactions | 2.28e-04 | 75 | 148 | 5 | int:THAP3 | |
| Interaction | MYH1 interactions | 2.42e-04 | 76 | 148 | 5 | int:MYH1 | |
| Interaction | DTL interactions | 2.49e-04 | 119 | 148 | 6 | int:DTL | |
| Interaction | SNCA interactions | FLNA PNKP MAP2 RTN4 APAF1 TPPP HNRNPA2B1 NEFM DST NAT10 ABCD3 PDIA2 TLN2 HSD17B4 HSPA9 | 2.59e-04 | 716 | 148 | 15 | int:SNCA |
| Interaction | MAGEB2 interactions | 2.63e-04 | 349 | 148 | 10 | int:MAGEB2 | |
| Interaction | ZNF668 interactions | 2.71e-04 | 226 | 148 | 8 | int:ZNF668 | |
| Interaction | ABT1 interactions | 2.98e-04 | 423 | 148 | 11 | int:ABT1 | |
| Interaction | GLI4 interactions | 3.24e-04 | 125 | 148 | 6 | int:GLI4 | |
| Interaction | DCAF17 interactions | 3.45e-04 | 19 | 148 | 3 | int:DCAF17 | |
| Interaction | H1-4 interactions | MON2 TPPP GRB10 YTHDC2 YBX3 REV3L KRR1 NKRF XIRP2 CTCF RBM19 NOM1 NAT10 DKC1 | 3.47e-04 | 656 | 148 | 14 | int:H1-4 |
| Interaction | FLT1 interactions | 3.62e-04 | 179 | 148 | 7 | int:FLT1 | |
| Interaction | H1-7 interactions | 3.62e-04 | 179 | 148 | 7 | int:H1-7 | |
| Interaction | BMI1 interactions | AGO2 YBX3 KRR1 NKRF NCBP3 PARP4 YAF2 DST CTCF NAT10 DKC1 CDC6 SPEN MAN1B1 | 3.64e-04 | 659 | 148 | 14 | int:BMI1 |
| Interaction | H1-1 interactions | TPPP YBX3 E4F1 REV3L KRR1 NKRF CTCF RBM19 NOM1 NAT10 DKC1 ZMYM4 | 3.73e-04 | 507 | 148 | 12 | int:H1-1 |
| Interaction | TTN interactions | 3.74e-04 | 299 | 148 | 9 | int:TTN | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 9.28e-06 | 8 | 101 | 3 | 658 | |
| GeneFamily | Tubulin polymerization promoting proteins | 9.24e-05 | 3 | 101 | 2 | 1240 | |
| GeneFamily | Dyneins, axonemal | 1.09e-04 | 17 | 101 | 3 | 536 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.46e-04 | 8 | 101 | 2 | 939 | |
| GeneFamily | Argonaute/PIWI family | 8.46e-04 | 8 | 101 | 2 | 408 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.08e-03 | 9 | 101 | 2 | 1234 | |
| GeneFamily | Fibronectin type III domain containing | 2.04e-03 | 160 | 101 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.10e-03 | 161 | 101 | 5 | 593 | |
| GeneFamily | Myosin heavy chains | 3.09e-03 | 15 | 101 | 2 | 1098 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | STON1 ACADVL CENPE ETFB SRP54 HMGCS1 ODC1 PSTPIP2 HNRNPA2B1 PAICS TRAP1 GK CCT5 TMEM106C DKC1 CDC6 HSD17B4 HSPA9 SNX5 | 1.03e-08 | 669 | 150 | 19 | M18635 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK AGO2 ATR CENPE DOCK9 TDG REV3L BPTF YAF2 DST BRCA2 ST3GAL5 CTCF WBP4 PRKACB NUMB SPEN ZMYM4 | 2.10e-06 | 856 | 150 | 18 | M4500 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | ATP23 ACADVL CENPE SPTA1 ETFB GRB10 YBX3 PAICS LRR1 TRAP1 BRCA2 CCT5 WBP4 NAT10 FUNDC2 DKC1 TLN2 LSM2 CDC6 HSD17B4 MAP2K3 HSPA9 | 3.51e-06 | 1271 | 150 | 22 | M39197 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 7.68e-06 | 432 | 150 | 12 | MM419 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | ATR CENPE TDG ODC1 PIAS2 HNRNPA2B1 PAICS YAF2 BRCA2 CCT5 CTCF TMEM106C TGDS DKC1 CDC6 HSPA9 | 8.04e-06 | 761 | 150 | 16 | M11961 |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 8.06e-06 | 48 | 150 | 5 | M16123 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 1.16e-05 | 307 | 150 | 10 | M19745 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | MYH1 MYH2 SLK AP1S3 MAP2 HMGCS1 ODC1 ST3GAL5 HSPA9 TNS3 MYBPC1 | 1.24e-05 | 379 | 150 | 11 | M1885 |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | UACA CENPE TNC DCTN2 ETFB SAE1 HNRNPA2B1 PAICS ARPC2 TRAP1 BRCA2 CCT5 TMEM106C DKC1 LSM2 CDC6 HSPA9 | 1.46e-05 | 891 | 150 | 17 | M41654 |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 2.08e-05 | 200 | 150 | 8 | M8308 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 2.08e-05 | 200 | 150 | 8 | M6193 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 2.08e-05 | 200 | 150 | 8 | M3891 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.08e-05 | 200 | 150 | 8 | M3188 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 2.57e-05 | 206 | 150 | 8 | M14134 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 2.95e-05 | 153 | 150 | 7 | M18058 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | STON1 ATR SRP54 HMGCS1 KRR1 SARNP PARP4 YAF2 WBP4 CFDP1 DKC1 SNX5 | 5.02e-05 | 523 | 150 | 12 | M12707 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | PNKP SAE1 YBX3 ODC1 TRAP1 BRCA2 CCT5 NAT10 DKC1 LSM2 CDC6 MAN1B1 SNX5 | 5.33e-05 | 612 | 150 | 13 | M4772 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 5.62e-05 | 230 | 150 | 8 | M11563 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 5.76e-05 | 170 | 150 | 7 | M6762 | |
| Coexpression | IBRAHIM_NRF2_UP | MAP2 RTN4 SRP54 ODC1 ARPC2 KIF3B CCT5 RBM19 ABCD3 DKC1 NUMB HSPA9 | 6.01e-05 | 533 | 150 | 12 | M42510 |
| Coexpression | DANG_MYC_TARGETS_UP | 1.06e-04 | 130 | 150 | 6 | M6506 | |
| Coexpression | PGF_UP.V1_UP | 1.16e-04 | 190 | 150 | 7 | M2674 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | NDNF STON1 TPPP YBX3 BCAN DNAH7 FREM2 DST KCNK2 TPPP3 CFAP44 PREX1 | 1.21e-04 | 574 | 150 | 12 | M39056 |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_UP | 1.32e-04 | 410 | 150 | 10 | M4399 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.38e-04 | 86 | 150 | 5 | M39247 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN | 1.45e-04 | 197 | 150 | 7 | M10015 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 1.49e-04 | 198 | 150 | 7 | M3171 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 1.54e-04 | 199 | 150 | 7 | M9422 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 1.54e-04 | 199 | 150 | 7 | M8314 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 1.54e-04 | 199 | 150 | 7 | M8371 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN | 1.54e-04 | 199 | 150 | 7 | M9170 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN | 1.59e-04 | 200 | 150 | 7 | M4593 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.59e-04 | 200 | 150 | 7 | M8500 | |
| Coexpression | GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP | 1.59e-04 | 200 | 150 | 7 | M7352 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN | 1.59e-04 | 200 | 150 | 7 | M5288 | |
| Coexpression | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN | 1.65e-04 | 48 | 150 | 4 | M2138 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN | 1.80e-04 | 91 | 150 | 5 | M2154 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 1.92e-04 | 145 | 150 | 6 | M3045 | |
| Coexpression | KIM_MYCL1_AMPLIFICATION_TARGETS_DN | 1.95e-04 | 20 | 150 | 3 | M5624 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.08e-04 | 434 | 150 | 10 | M15150 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 2.28e-04 | 439 | 150 | 10 | M39054 | |
| Coexpression | ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT | 2.42e-04 | 97 | 150 | 5 | M39213 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.64e-04 | 534 | 150 | 11 | MM1054 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.68e-04 | 448 | 150 | 10 | MM1044 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 2.80e-04 | 55 | 150 | 4 | M2043 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.37e-09 | 162 | 150 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 184 | 150 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 184 | 150 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-07 | 184 | 150 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.86e-07 | 191 | 150 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 192 | 150 | 8 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 192 | 150 | 8 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.35e-07 | 195 | 150 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.76e-07 | 198 | 150 | 8 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-07 | 200 | 150 | 8 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-06 | 170 | 150 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 170 | 150 | 7 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 174 | 150 | 7 | ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 178 | 150 | 7 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-06 | 181 | 150 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.07e-06 | 184 | 150 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-06 | 184 | 150 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-06 | 185 | 150 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 186 | 150 | 7 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 186 | 150 | 7 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.66e-06 | 189 | 150 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-06 | 190 | 150 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-06 | 190 | 150 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 191 | 150 | 7 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.20e-06 | 193 | 150 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.20e-06 | 193 | 150 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 4.81e-06 | 197 | 150 | 7 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 4.97e-06 | 198 | 150 | 7 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | HSPCs|World / Lineage and Cell class | 5.14e-06 | 199 | 150 | 7 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.31e-06 | 200 | 150 | 7 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.31e-06 | 200 | 150 | 7 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 145 | 150 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.55e-05 | 157 | 150 | 6 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 158 | 150 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 158 | 150 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.77e-05 | 174 | 150 | 6 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 2.77e-05 | 174 | 150 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 174 | 150 | 6 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.95e-05 | 176 | 150 | 6 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-05 | 176 | 150 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 177 | 150 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 177 | 150 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 177 | 150 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 179 | 150 | 6 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.35e-05 | 180 | 150 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.56e-05 | 182 | 150 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 183 | 150 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 184 | 150 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | COVID-19-Heart-Fib_+_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 112 | 150 | 5 | d00ee6b19e41a35450681fe676885983536d6292 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 185 | 150 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.90e-05 | 185 | 150 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 3.90e-05 | 185 | 150 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-05 | 187 | 150 | 6 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.27e-05 | 188 | 150 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.40e-05 | 189 | 150 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | d2b008f98739c6af7ee63b643011a240db20e4d8 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 189 | 150 | 6 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 190 | 150 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.53e-05 | 190 | 150 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 191 | 150 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.66e-05 | 191 | 150 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-Marrow-KLS-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 51327ba28b2e3052087fa0fc9b7c0339dc09a1e3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-05 | 191 | 150 | 6 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 4.80e-05 | 192 | 150 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 193 | 150 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.94e-05 | 193 | 150 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-05 | 193 | 150 | 6 | c3522693439c23830d8a3f20854539ccb7a666e0 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-05 | 194 | 150 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.08e-05 | 194 | 150 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-05 | 194 | 150 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.08e-05 | 194 | 150 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-05 | 195 | 150 | 6 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 5.38e-05 | 196 | 150 | 6 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.38e-05 | 196 | 150 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | 27364b577d77aefaa147abb346c46fce61e28ec3 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-05 | 197 | 150 | 6 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 5.53e-05 | 197 | 150 | 6 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 197 | 150 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-05 | 197 | 150 | 6 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-05 | 197 | 150 | 6 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-05 | 197 | 150 | 6 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-05 | 198 | 150 | 6 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.69e-05 | 198 | 150 | 6 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.69e-05 | 198 | 150 | 6 | d499dced27b0c0e21acfda2c20fa5c114f605085 | |
| Computational | Intracellular transport (MT cytoskeleton and motors). | 2.69e-05 | 21 | 92 | 4 | MODULE_253 | |
| Computational | Genes in the cancer module 196. | 3.93e-05 | 23 | 92 | 4 | MODULE_196 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.44e-05 | 50 | 92 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.34e-05 | 13 | 147 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.28e-05 | 15 | 147 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 9.70e-05 | 48 | 147 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 1.11e-04 | 19 | 147 | 3 | C1292778 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.47e-04 | 4 | 147 | 2 | EFO_0020830 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.62e-04 | 102 | 147 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Seckel syndrome | 1.74e-04 | 22 | 147 | 3 | C0265202 | |
| Disease | Hypertrophic Cardiomyopathy | 1.90e-04 | 57 | 147 | 4 | C0007194 | |
| Disease | macula measurement | 3.82e-04 | 189 | 147 | 6 | EFO_0008375 | |
| Disease | neutropenia (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 6.77e-04 | 8 | 147 | 2 | C0266294 | |
| Disease | Sudden Cardiac Death | 6.77e-04 | 8 | 147 | 2 | C0085298 | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0008240 | |
| Disease | pyoderma gangrenosum | 8.67e-04 | 9 | 147 | 2 | EFO_0006835 | |
| Disease | Disorder of fatty acid metabolism | 8.67e-04 | 9 | 147 | 2 | cv:C0268634 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | response to virus | 1.32e-03 | 11 | 147 | 2 | GO_0009615 | |
| Disease | red blood cell density measurement | CACNA1C SLK STON1 ATR DNAH10 MYO9A SPTA1 DST ST3GAL5 PLCL2 PREX1 TNS3 | 1.56e-03 | 880 | 147 | 12 | EFO_0007978 |
| Disease | distal myopathy (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Zellweger Spectrum | 1.85e-03 | 13 | 147 | 2 | C3658299 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.85e-03 | 13 | 147 | 2 | C0369183 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.85e-03 | 13 | 147 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Zellweger-Like Syndrome | 1.85e-03 | 13 | 147 | 2 | C0751594 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.85e-03 | 13 | 147 | 2 | C1261502 | |
| Disease | forced expiratory volume | STON1 DOCK9 CNTLN KIF3B DST TMEM267 MYPN CFDP1 KCNK2 PREX1 MYBPC1 | 2.06e-03 | 789 | 147 | 11 | EFO_0004314 |
| Disease | skin melanoma (is_implicated_in) | 2.16e-03 | 14 | 147 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.16e-03 | 14 | 147 | 2 | cv:C2931907 | |
| Disease | high grade glioma (biomarker_via_orthology) | 2.48e-03 | 15 | 147 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Zellweger Syndrome | 2.83e-03 | 16 | 147 | 2 | C0043459 | |
| Disease | Antibody Deficiency Syndrome | 3.19e-03 | 17 | 147 | 2 | C0003257 | |
| Disease | esophageal adenocarcinoma | 3.58e-03 | 18 | 147 | 2 | EFO_0000478 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 SLK AGO2 STON1 ATR SPTA1 AGO4 CTCF PLCL2 PDIA2 MAP2K3 PREX1 TNS3 | 3.62e-03 | 1105 | 147 | 13 | EFO_0004528 |
| Disease | melanoma | 3.70e-03 | 126 | 147 | 4 | EFO_0000756 | |
| Disease | cystathionine measurement | 3.99e-03 | 19 | 147 | 2 | EFO_0010474 | |
| Disease | susceptibility to hepatitis B infection measurement | 4.04e-03 | 64 | 147 | 3 | EFO_0008405 | |
| Disease | white matter hyperintensity measurement | 4.15e-03 | 302 | 147 | 6 | EFO_0005665 | |
| Disease | keratoconus | 4.41e-03 | 66 | 147 | 3 | MONDO_0015486 | |
| Disease | urinary microalbumin measurement | 4.42e-03 | 20 | 147 | 2 | EFO_0010967 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EIFSKEVFGVKVKNL | 236 | Q13569 | |
| KTGISKSKEAFIEAV | 16 | Q9BXU7 | |
| VFKAETGEKLLEIKA | 641 | O14727 | |
| VTKDVIKEFADDGVK | 86 | Q6DHV7 | |
| VEAIVEESETFIKGK | 6 | P49711 | |
| KVEEFTTFVKALAKE | 1276 | Q9NXG0 | |
| GKEETKIIVSKISDI | 2486 | Q8IZF6 | |
| VTVDVRTKKVVFKDG | 271 | Q96NN9 | |
| AVKKFVESEDDPVVK | 31 | Q5MAI5 | |
| STVFKDDDDVVIGKV | 166 | O15144 | |
| KISAKVISGVLKETE | 116 | Q3ZCU0 | |
| VKFTKEIRGLKVEVT | 246 | Q9HCK5 | |
| EVEKIKTTVKESATE | 116 | Q13561 | |
| VATESKTVIKVEKGD | 1721 | Q12830 | |
| KTVIKVEKGDKQTVV | 1726 | Q12830 | |
| VTIQEESIIEKGKKF | 1091 | Q96MT7 | |
| TDAEAGKIVKKEAVT | 151 | Q5H9R4 | |
| KEVIKEFSNVSVGKL | 421 | O75185 | |
| VKFTKEIKGLKVEIT | 256 | Q9UKV8 | |
| EVGTETIIDKSKSVK | 91 | Q01581 | |
| TTEEKLKEVFSKVGT | 741 | Q9Y4C8 | |
| EKLFVKLATSKTAVE | 171 | Q9H939 | |
| VVKIEDIETFKEALK | 1361 | Q2KHR3 | |
| TEKVSFLEKKVTELE | 341 | Q86YS3 | |
| KDVKDTVTEILDTKV | 296 | Q8NGL1 | |
| GEIQETSKKIAVKAI | 121 | Q96PC3 | |
| TVLGTEIVAFKEKEV | 301 | Q9H790 | |
| SSDAVEVKVKGVVFL | 146 | Q96GW7 | |
| ISKEVAKKAVDEVFE | 196 | Q9Y6H3 | |
| EVVFGVDLKKVDSTK | 161 | O15480 | |
| FFKSLVGKDVVVELK | 6 | Q9Y333 | |
| VVLEGEAKFEEVSKI | 776 | Q5H9T9 | |
| TKFVDEGKATVRLKE | 71 | Q96L50 | |
| TSGDVKVEEKLDKVI | 1541 | Q03001 | |
| LDKVVTTAIKEETEK | 3751 | Q03001 | |
| TTAIKEETEKVAAVK | 3756 | Q03001 | |
| TDVLEIEVKDKFAKS | 276 | Q76N89 | |
| EVGVKEVKTKVNSTL | 2651 | Q8NDA2 | |
| VTETAGKEEKVKGFL | 341 | Q8NHP7 | |
| ADKTVIKFGETKFSV | 2246 | Q5SZK8 | |
| LRVISKKTKEEVGEF | 311 | O95069 | |
| VTVLEKLIKEFQDKG | 641 | P50747 | |
| ILETIVKEFGKVKQT | 2746 | Q5CZC0 | |
| FATIAVTGEKKKEEI | 196 | Q9UKX2 | |
| EKAEVKEKVVLSESV | 1491 | O60437 | |
| KEKVVLSESVQVEKG | 1496 | O60437 | |
| TGIDVTSKEAIEKKE | 76 | Q53F19 | |
| KTVELKDGKITDVFV | 341 | Q8TB73 | |
| GTRAVQEKETKIKDF | 586 | Q96MY7 | |
| STETKIDVASIKEKV | 336 | Q13601 | |
| FATIAVTGEKKKEEV | 196 | P12882 | |
| LTKDTVVLFKKFDEG | 216 | Q13087 | |
| KEAAESGIIKVKTIA | 36 | Q7Z3U7 | |
| QDTVEKICIKEIGTK | 766 | Q9UKK3 | |
| IVKEFKRETGVDLTK | 286 | P38646 | |
| TEKLAGVKQEVIKES | 1401 | Q9C091 | |
| AKAVLKFIEGISEKT | 261 | Q9H0A0 | |
| LTGDKKFQEAVEKVT | 411 | Q9UKM7 | |
| VKDDSDIVKKEFASI | 696 | Q13535 | |
| DATEVKVIIEKSDKF | 776 | Q6YHK3 | |
| EKVKITKVFDFAGEE | 161 | Q9UEE9 | |
| REKTVTGEFIDKESK | 381 | O75054 | |
| TAKKGSEVESVKEFL | 6 | P22694 | |
| SEVESVKEFLAKAKE | 11 | P22694 | |
| VGESKEEKIELKSIT | 796 | Q13936 | |
| FVEVIKDSTPVDKTK | 1841 | Q8NF50 | |
| EVKSFEEKFGKRILV | 356 | Q9BZ29 | |
| EVDLIGFVVSVVKKT | 3071 | P51587 | |
| EFTLKKFTKVEDIIE | 491 | Q99715 | |
| VVGIEAEKVSKEKAI | 3086 | Q9UFH2 | |
| EKVDVGKDQEFTVKS | 981 | P21333 | |
| VEEGEKVVKTALDAF | 76 | P51659 | |
| KDEFKAVKALVSSVI | 1976 | A8TX70 | |
| VADTVKAKVFKDVFL | 811 | P01031 | |
| VAEKDSEITFIKKVT | 1591 | P01031 | |
| EKESVEVAKTEKIVK | 2631 | Q8WXX0 | |
| EVAKTEKIVKADETI | 2636 | Q8WXX0 | |
| EKSPETFKEAVKAII | 166 | O95395 | |
| EETKNKVVSFLEKTG | 736 | Q9NSG2 | |
| KTSEEIEKLAKEVGT | 346 | P32189 | |
| ETRLTKVFFKIEEKE | 526 | Q99741 | |
| KVFSEDGTSKVVEIL | 171 | Q13322 | |
| VTEEEGINVFLKSKK | 76 | Q9NYL5 | |
| KIRFSVSKDVVVSKE | 276 | Q66K89 | |
| LKEFEGKTLVSVTKE | 241 | Q58FG1 | |
| ESAKKEVVAEVVKAP | 421 | O60832 | |
| VTAAIKEVAIEKAVK | 1386 | Q8IVF4 | |
| PFTEEKVEDVKALVK | 306 | Q8N697 | |
| TQEGIVILKKKVDFE | 311 | Q9H159 | |
| KEFEKEISATKATVE | 2476 | Q02224 | |
| GVKAVKVADIEKASI | 36 | O14625 | |
| SEDVKLKFEEITGVI | 241 | P11926 | |
| TVKTDIKVKGEETEE | 1326 | Q5THK1 | |
| VTVASEASKKKVDVI | 456 | O75928 | |
| KKTDIAAFVKEILGE | 331 | P46734 | |
| AKKAETDKIVVGSSV | 216 | P49757 | |
| KAEEVVSFVKKNVLV | 161 | Q9BWH2 | |
| TKLVKEDEVVSSEKA | 351 | Q9NQC3 | |
| VLVDDDGIKVVKVTF | 111 | Q9BVX2 | |
| FKKIKGIVEESVTGV | 326 | Q96HN2 | |
| TLKKTRKFIVDGVEV | 791 | Q9H2G2 | |
| FKDKVDVASVIVTKL | 236 | P61011 | |
| TVDVAAEKKVVKITS | 81 | P82979 | |
| KGFIDVSKIKCVEIV | 51 | P42680 | |
| SEVIAEAVGVKKTVK | 486 | O15226 | |
| TVLKDEGVVVKKVSK | 196 | Q8NA58 | |
| GVKVETTEDLVAKLK | 236 | P38117 | |
| KAGTEVTKEEFIEVF | 321 | Q9UPR0 | |
| FKILIEGTVKNEKSD | 76 | Q8IWT1 | |
| GFDIEEKNKAVVVKS | 636 | Q8TCU6 | |
| TDLKKIFSVKEESLV | 341 | Q5VXU9 | |
| VTTETKFLLKLVKEG | 391 | Q9UNP4 | |
| DTKLIKGVIVDKDFS | 221 | P48643 | |
| EHEFVEEKTKVAKVS | 171 | Q9UBE0 | |
| ILKKLIGTFTEKDIE | 486 | Q5C9Z4 | |
| DDLKKKTVIEIEFST | 86 | Q5MNZ6 | |
| EFKAKVEAVVEKLGV | 231 | Q96T60 | |
| GDKLVIVKFVQDTSK | 1156 | Q68CZ2 | |
| GLKETKDVDFAVVLK | 116 | Q8IUC4 | |
| VFTGEKVAVKVIDKT | 36 | Q9NRH2 | |
| KVLTVKVNISDGVKD | 446 | Q8N5C6 | |
| FTVDEKEVVVGTDKL | 151 | Q13326 | |
| EGKKERAVVDKVFFS | 51 | P28288 | |
| ATGAVKEKITAFVVE | 271 | P49748 | |
| TDVVEAFLTVLKKGK | 236 | O95455 | |
| TKKTITEEVIQGDVK | 1121 | A4UGR9 | |
| KIEFGVDVTTKEIVL | 191 | P22234 | |
| DAEKKVLATKVLGTV | 81 | P16989 | |
| FVAKTEDVGKKIEIT | 671 | Q7Z392 | |
| KEKGLSSHVEVVEKE | 941 | Q96T58 | |
| VKKLFVGGIKEDTEE | 111 | P22626 | |
| ELTGVIVIDKDKTVF | 2341 | O60673 | |
| KVTKEGKFVESAVIT | 426 | Q9Y6Q2 | |
| VKDLSSFVTKSVKEI | 176 | O15066 | |
| EKEKKESLFVVSGDT | 291 | P58005 | |
| EGLKFKSIKETSVEV | 716 | P24821 | |
| GDLTVIITDFKEKTK | 121 | Q8IY57 | |
| GEPKVVFKEKTVTSL | 331 | O75554 | |
| VKSADEVLFTGVKEV | 191 | Q9Y5X3 | |
| KIITVDKTATKLIGD | 531 | P02549 | |
| EREGKIVESSKDFKV | 821 | Q6AHZ1 | |
| EGTKVSETEVKEKVA | 1101 | P11137 | |
| DIVFSKVKGKSARVI | 56 | Q9BW30 | |
| QIKEAFEKEVGIIKA | 1171 | Q9BZF9 | |
| STLKIKFLEKEDEVV | 96 | A0A075B6L2 | |
| VFVIDSGKVKEKSFD | 701 | Q9H6S0 | |
| VTVTDVDIVFSKIKG | 91 | O94811 | |
| EFDKKKLISVETDIV | 541 | Q12931 | |
| AEKFAKTVVDVGEKT | 451 | Q86TV6 | |
| KTVVDVGEKTSEFKA | 456 | Q86TV6 | |
| GKADDDDVVVKTKFV | 2481 | Q9Y4G6 | |
| AVVTGIKKKTDFGEI | 66 | Q0VDI3 | |
| KIVKETVRFSGADKS | 736 | Q5VZL5 | |
| VEERATVTKKAFGKQ | 756 | Q86UW6 | |
| DTLVDVVFKKALKEF | 1886 | B2RTY4 | |
| VVLVGDVFKKLQKEA | 1331 | P52179 | |
| VGEDITFIAKVKAED | 71 | Q00872 | |
| VIAGSSKVKFDLKVI | 81 | Q14896 | |
| SFSLELSVVAKEVKK | 1156 | Q86TC9 | |
| DKSEEKVVVTKTVEK | 846 | P07197 | |
| KVVVTKTVEKITSEG | 851 | P07197 | |
| HEETFEEKLVSTKKV | 886 | P07197 |